Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
1,517,324
-
Shares change
-
+557,741
-
Total reported value, excl. options
-
$94,463,969
-
Value change
-
+$34,775,889
-
Put/Call ratio
-
120%
-
Number of buys
-
18
-
Number of sells
-
16
-
Price
-
$62.25
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2020
As of 30 Jun 2020 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,517,324 shares of stock of the company.
Largest 10 holders included Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), GOLDMAN SACHS GROUP INC, CLS Investments, LLC, Orion Portfolio Solutions, LLC, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Tower Research Capital LLC (TRC), and LPL Financial LLC.
This table shows 54 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.